We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics and Nanoplastics in human tissues: Systematic review of evidence, analytical protocols, and methodological challenges
Summary
This systematic review pulls together evidence on microplastics and nanoplastics found in human tissues like lungs, liver, and placenta. It confirms that tiny plastic particles are accumulating in our bodies, though detection methods still vary widely between studies, making it hard to compare results.
Microplastics and NanoPlastics (MNP) have emerged as ubiquitous environmental contaminants with potential implications for human health. This systematic review synthesizes current evidence on the occurrence of MNP in human solid tissues and critically evaluates the analytical protocols employed for their detection and quantification. A comprehensive literature search conducted in September 2025 across MEDLINE, EMBASE, and the Cochrane Library, in accordance with PRISMA guidelines, identified 26 eligible studies encompassing 564 human samples from diverse biological matrices, including placenta, lung, liver, blood, and bone. Polyethylene, polypropylene, and polyvinyl chloride were the most frequently detected polymers, while particle sizes predominantly ranged between 20 and 100 μm. Analytical techniques varied substantially across studies, with Raman and Fourier-transform infrared (FTIR) spectroscopy representing the most widely applied methods, often complemented by microscopy or pyrolysis–GC/MS for polymer confirmation. Reported MNPs abundances ranged from less than one to several thousand particles per gram of tissue, reflecting the lack of standardized procedures for extraction, quantification, and contamination control. Recent investigations have increasingly implemented plastic-free workflows and procedural blanks, leading to improved reliability and reduced overestimation of MNP burden. Nevertheless, persistent methodological heterogeneity continues to hinder cross-study comparability and the establishment of true human tissue loads. Preliminary correlations between MNP accumulation and clinical or pathological parameters have been observed, but causal links remain unconfirmed. This review highlights the urgent need for internationally harmonized protocols, rigorous contamination prevention, and standardized reporting to ensure reliable biomonitoring and clarify the potential health implications of microplastic exposure in humans.
Sign in to start a discussion.
More Papers Like This
Systemic Accumulation and Distribution of Micro- and Nanoplastics in Human Tissues and Their Impact on Health: A Systematic Review
This systematic review synthesizes human evidence on the presence of micro- and nanoplastics in body tissues and fluids, including blood, lungs, placenta, breast milk, and liver. The research confirms that plastic particles can cross biological barriers and accumulate in multiple organ systems. While the long-term health effects are still being studied, the widespread presence of plastics inside the human body raises significant health concerns.
Detection of microplastics in human tissues and organs: A scoping review
This scoping review summarizes studies that have detected microplastics in various human tissues and organs. The review found that microplastics enter the body through multiple routes and have distinct characteristics depending on where they accumulate. The variety of analytical techniques used across studies makes direct comparisons difficult, highlighting the need for standardized methods.
Microplastics in Human Tissues: Sources, Distribution, Toxicological Effects, and Health Implications
Researchers reviewed the growing body of evidence that microplastics accumulate in human tissues — including lung, blood, placenta, breast milk, and heart tissue — where they can trigger inflammation, oxidative stress, and cell death. The review highlights urgent knowledge gaps around how plastic particles move through the body and what their long-term health effects may be.
Unveiling the presence of micro and nanoplastics in human biological matrices: A systematic review covering the latest five years from 2020 to 2025
This systematic review covering 2020-2025 confirmed the presence of micro- and nanoplastics in human blood, placenta, lungs, liver, kidneys, and other biological matrices. The findings demonstrate that plastic particles are accumulating in human tissues through ingestion, inhalation, and dermal contact, raising urgent questions about long-term health consequences.
From food-to-human microplastics and nanoplastics exposure and health effects: A review on food, animal and human monitoring data
This review summarizes existing research on how microplastics and nanoplastics move from food into animal and human tissues, and what health effects they may cause. Studies show these particles have been found accumulating in organs including the liver, lungs, placenta, and blood, with their size and chemical properties determining where they end up in the body. The authors stress the need for standardized testing methods and human biomonitoring to better understand the real health burden of microplastics in our food supply.